Babb J - Search Results

1

An epistatic interaction controls the latency of a transgene-induced mammary tumor.

Le Voyer T, Lu Z, Babb J, Lifsted T, Williams M, Hunter K. Le Voyer T, et al. Among authors: babb j. Mamm Genome. 2000 Oct;11(10):883-9. doi: 10.1007/s003350010163. Mamm Genome. 2000. PMID: 11003704

2

Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936.

Cheng JD, Babb JS, Langer C, Aamdal S, Robert F, Engelhardt LR, Fernberg O, Schiller J, Forsberg G, Alpaugh RK, Weiner LM, Rogatko A. Cheng JD, et al. Among authors: babb js. J Clin Oncol. 2004 Feb 15;22(4):602-9. doi: 10.1200/JCO.2004.12.034. J Clin Oncol. 2004. PMID: 14966084 Clinical Trial.

3

Gender differences in genetic susceptibility for lung cancer.

Dresler CM, Fratelli C, Babb J, Everley L, Evans AA, Clapper ML. Dresler CM, et al. Among authors: babb j. Lung Cancer. 2000 Dec;30(3):153-60. doi: 10.1016/s0169-5002(00)00163-x. Lung Cancer. 2000. PMID: 11137199

4

Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential.

Wu H, Barusevicius A, Babb J, Klein-Szanto A, Godwin A, Elenitsas R, Gelfand JM, Lessin S, Seykora JT. Wu H, et al. Among authors: babb j. J Cutan Pathol. 2005 Feb;32(2):125-30. doi: 10.1111/j.0303-6987.2005.00282.x. J Cutan Pathol. 2005. PMID: 15606670

5

Promoter hypermethylation profile of kidney cancer.

Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P. Dulaimi E, et al. Among authors: babb js. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3972-9. doi: 10.1158/1078-0432.CCR-04-0175. Clin Cancer Res. 2004. PMID: 15217927

6

Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.

Cheng JD, Werness BA, Babb JS, Meropol NJ. Cheng JD, et al. Among authors: babb js. Clin Cancer Res. 1999 May;5(5):1057-62. Clin Cancer Res. 1999. PMID: 10353738

7

Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia.

Stewart SL, Querec TD, Ochman AR, Gruver BN, Bao R, Babb JS, Wong TS, Koutroukides T, Pinnola AD, Klein-Szanto A, Hamilton TC, Patriotis C. Stewart SL, et al. Cancer Res. 2004 Nov 15;64(22):8177-83. doi: 10.1158/0008-5472.CAN-04-1702. Cancer Res. 2004. PMID: 15548682

8

Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer.

Fang CY, Miller SM, Malick J, Babb J, Hurley KE, Engstrom PF, Daly MB. Fang CY, et al. Among authors: babb j. Prev Med. 2003 Nov;37(5):424-31. doi: 10.1016/s0091-7435(03)00163-4. Prev Med. 2003. PMID: 14572427

9

E2F-1: a proliferative marker of breast neoplasia.

Zhang SY, Liu SC, Al-Saleem LF, Holloran D, Babb J, Guo X, Klein-Szanto AJ. Zhang SY, et al. Among authors: babb j. Cancer Epidemiol Biomarkers Prev. 2000 Apr;9(4):395-401. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10794484

10

Patient specific dosing in a cancer phase I clinical trial.

Babb JS, Rogatko A. Babb JS, et al. Stat Med. 2001 Jul 30;20(14):2079-90. doi: 10.1002/sim.848. Stat Med. 2001. PMID: 11439422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

837 results

Search Page

Filters